Join Andrew J. Armstrong, MD, ScM and Bridget Koontz, MD from Duke Cancer Institute as they present their expertise on a range of cases pertaining to castrate resistant prostate cancer (CRPC).

Background: The current NCCN Clinical Practice Guidelines in Oncology for Prostate Cancer recommend long-term androgen deprivation therapy (ADT) for all men with high-risk prostate cancer treated with external-beam radiation therapy (EBRT).

In this series of live, 1-hour CME/CE-certified meetings, expert faculty members will present an overview of CRPC and the current treatment landscape with an emphasis on interactive, case vignettes to highlight choice of therapy, toxicity management, and key issues in the multidisciplinary manage

In this series of live, 1-hour CME/CE-certified meetings, expert faculty members will present an overview of CRPC and the current treatment landscape with an emphasis on interactive, case vignettes to highlight choice of therapy, toxicity management, and key issues in the multidisciplinary manage

In this series of live, 1-hour CME/CE-certified meetings, expert faculty members will present an overview of CRPC and the current treatment landscape with an emphasis on interactive, case vignettes to highlight choice of therapy, toxicity management, and key issues in the multidisciplinary manage

This educational initiative addresses healthcare professionals’ need to be educated on practice-changing developments in the management of advanced genitourinary cancers that have taken center stage in recent years.

In this series of live, 1-hour CME/CE-certified meetings, expert faculty members will present an overview of CRPC and the current treatment landscape with an emphasis on interactive, case vignettes to highlight choice of therapy, toxicity management, and key issues in the multidisciplinary manage

In this series of live, 1-hour CME/CE-certified meetings, expert faculty members will present an overview of CRPC and the current treatment landscape with an emphasis on interactive, case vignettes to highlight choice of therapy, toxicity management, and key issues in the multidisciplinary manage

The NCCN Guidelines for Prostate Cancer address staging and risk assessment after an initial diagnosis of prostate cancer and management options for localized, regional, and metastatic disease.

A preponderance of clinical evidence supports a significant public health benefit for screening and early detection of prostate cancer in selected men.